Results
|
1.
|
Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2016
Citation: - European Heart Journal. 37(35):2701-9, 2016 Sep 14
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Abizaid A, Christiansen EH, Eeckhout E, Escaned J, Garcia-Garcia HM, Haude M, Ince H, Kaiser C, Lemos PA, Lim ST, Neumann FJ, Onuma Y, Toelg R, von Birgelen C, Waksman R, Wijns W
|
|
2.
|
|
|
3.
|
Five-year follow-up of the Sirolimus-Eluting Stents vs Vascular Brachytherapy for Bare Metal In-Stent Restenosis (SISR) trial. MedStar authors:
Year: 2012
Citation: - American Heart Journal. 163(3):438-45, 2012 Mar.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Alli OO, Cohen SA, Holmes DR Jr, Mauri L, Popma JJ, Satler L, Schleckser PA, SISR Investigators, Sketch MH Jr, Teirstein PS, Wang HP
|
|
4.
|
Clinical outcomes after treating acute coronary syndrome patients with a drug-eluting stent: results from REWARDS-EMI (Endeavor for Myocardial Infarction Registry). MedStar authors:
- Badr, Salem
- Barbash, Israel M
- Ben-Dor, Itsik
- Dvir, Danny
- Laynez-Carnicero, Ana
- Pichard, Augusto D
- Sardi, Gabriel L
- Satler, Lowell F
- Torguson, Rebecca
- Waksman, Ron
Citation: - Cardiovascular Revascularization Medicine. 14(3):128-33, 2013 May-Jun.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
- Observational Study
All authors: - Badr S, Barbash IM, Ben-Dor I, Dvir D, Laynez-Carnicero A, Pichard AD, Sardi GL, Satler LF, Torguson R, Waksman R
|
|
5.
|
Clinical and angiographic experience with a third-generation drug-eluting Orsiro stent in the treatment of single de novo coronary artery lesions (BIOFLOW-I): a prospective, first-in-man study. MedStar authors:
- Waksman, Ron
- Weissman, Neil J
Year: 2013
Citation: - Eurointervention. 8(9):1006-11, 2013 Jan 22.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
All authors: - Deleanu D, Dorobantu M, Hamon M, Niculescu R, Waksman R, Weissman NJ
|
|
6.
|
Polymer-free Biolimus A9-coated stents in the treatment of de novo coronary lesions with short DAPT: 9-month angiographic and clinical follow-up of the prospective, multicenter BioFreedom USA clinical trial. MedStar authors:
- Bastian, Roshni
- Chandra, Nina
- Garcia-Garcia, Hector M
- Leiboff, Roy
- Spad, Mia-Ashley
- Torguson, Rebecca
- Waksman, Ron
- Wang, John
Year: 2017
Citation: - Cardiovascular Revascularization Medicine. 18(7):475-481, 2017 Oct - Nov.
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
- MedStar Southern Maryland Hospital Center
- MedStar Union Memorial Hospital
Medline publication type:
All authors: - Adams G, Bastian R, Cannon L, Chandra N, DeGroot J, Garcia-Garcia HM, Kabour A, Kayo MW, Kereiakes DJ, Leiboff R, Piegari GN, Smeglin A, Solankhi N, Spad MA, Stoll HP, Torguson R, Waksman R, Wang J
|